Gonadotropin releasing hormone agonist treatment for severe menorrhagia in patients with contraindications to surgery

Paolo Vercellini; Augusto Ferrari; Alberto D'Alberton; Tiziano Motta; Renato Maggi; Piero Molteni

doi:10.1016/0028-2243(92)90197-7

Gonadotropin releasing hormone agonist treatment for severe menorrhagia in patients with contraindications to surgery

Paolo Vercellini, Augusto Ferrari, Alberto D'Alberton, Tiziano Motta, Renato Maggi, Piero Molteni

Fondazione IRCCS Ca' Granda- Ospedale Maggiore Policlinico

Research output: Contribution to journal › Article

Abstract

Four patients with heavy menorrhagia, severe iron-deficiency anemia and contraindications to surgery were treated with a gonadotropin-releasing hormone agonist in a depot formulation. At 2 months of therapy they were all amenorrheic, and at 6 months the hematologic values had improved markedly. Gonadotropin-releasing hormone agonists may obviate emergency surgery in patients at high surgical risk or could constitute the first line of sequential therapeutic regimens, once general health conditions have improved.

Original language	English
Pages (from-to)	70-72
Number of pages	3
Journal	European Journal of Obstetrics and Gynecology and Reproductive Biology
Volume	45
Issue number	1
DOIs	https://doi.org/10.1016/0028-2243(92)90197-7
Publication status	Published - Jun 16 1992

Fingerprint

Keywords

Gonadotropin releasing hormone agonist
Menorrhagia

ASJC Scopus subject areas

Obstetrics and Gynaecology
Reproductive Medicine

Cite this

Vercellini, P., Ferrari, A., D'Alberton, A., Motta, T., Maggi, R., & Molteni, P. (1992). Gonadotropin releasing hormone agonist treatment for severe menorrhagia in patients with contraindications to surgery. European Journal of Obstetrics and Gynecology and Reproductive Biology, 45(1), 70-72. https://doi.org/10.1016/0028-2243(92)90197-7

Gonadotropin releasing hormone agonist treatment for severe menorrhagia in patients with contraindications to surgery. / Vercellini, Paolo; Ferrari, Augusto; D'Alberton, Alberto; Motta, Tiziano; Maggi, Renato; Molteni, Piero.

In: European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 45, No. 1, 16.06.1992, p. 70-72.

Research output: Contribution to journal › Article

@article{8b84b3e4238e4168af52ff28f907219f,

title = "Gonadotropin releasing hormone agonist treatment for severe menorrhagia in patients with contraindications to surgery",

abstract = "Four patients with heavy menorrhagia, severe iron-deficiency anemia and contraindications to surgery were treated with a gonadotropin-releasing hormone agonist in a depot formulation. At 2 months of therapy they were all amenorrheic, and at 6 months the hematologic values had improved markedly. Gonadotropin-releasing hormone agonists may obviate emergency surgery in patients at high surgical risk or could constitute the first line of sequential therapeutic regimens, once general health conditions have improved.",

keywords = "Gonadotropin releasing hormone agonist, Menorrhagia",

author = "Paolo Vercellini and Augusto Ferrari and Alberto D'Alberton and Tiziano Motta and Renato Maggi and Piero Molteni",

year = "1992",

month = jun,

day = "16",

doi = "10.1016/0028-2243(92)90197-7",

language = "English",

volume = "45",

pages = "70--72",

journal = "European Journal of Obstetrics, Gynecology and Reproductive Biology",

issn = "0028-2243",

publisher = "Elsevier Ireland Ltd",

number = "1",

}

TY - JOUR

T1 - Gonadotropin releasing hormone agonist treatment for severe menorrhagia in patients with contraindications to surgery

AU - Vercellini, Paolo

AU - Ferrari, Augusto

AU - D'Alberton, Alberto

AU - Motta, Tiziano

AU - Maggi, Renato

AU - Molteni, Piero

PY - 1992/6/16

Y1 - 1992/6/16

N2 - Four patients with heavy menorrhagia, severe iron-deficiency anemia and contraindications to surgery were treated with a gonadotropin-releasing hormone agonist in a depot formulation. At 2 months of therapy they were all amenorrheic, and at 6 months the hematologic values had improved markedly. Gonadotropin-releasing hormone agonists may obviate emergency surgery in patients at high surgical risk or could constitute the first line of sequential therapeutic regimens, once general health conditions have improved.

AB - Four patients with heavy menorrhagia, severe iron-deficiency anemia and contraindications to surgery were treated with a gonadotropin-releasing hormone agonist in a depot formulation. At 2 months of therapy they were all amenorrheic, and at 6 months the hematologic values had improved markedly. Gonadotropin-releasing hormone agonists may obviate emergency surgery in patients at high surgical risk or could constitute the first line of sequential therapeutic regimens, once general health conditions have improved.

KW - Gonadotropin releasing hormone agonist

KW - Menorrhagia

UR - http://www.scopus.com/inward/record.url?scp=0026653421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026653421&partnerID=8YFLogxK

U2 - 10.1016/0028-2243(92)90197-7

DO - 10.1016/0028-2243(92)90197-7

M3 - Article

C2 - 1535604

AN - SCOPUS:0026653421

VL - 45

SP - 70

EP - 72

JO - European Journal of Obstetrics, Gynecology and Reproductive Biology

JF - European Journal of Obstetrics, Gynecology and Reproductive Biology

SN - 0028-2243

IS - 1

ER -

Access to Document

10.1016/0028-2243(92)90197-7